At least 30 cases of thrombosis they were identified by British regulators. Rare were found clots blood among people vaccinated with AstraZeneca in it United Kingdom. However, they have emphasized the benefits of this preparation to combat COVID-19.
The Regulatory Agency for Medicines and Health Care (MHRA) insisted this Friday that the risks associated with these clots are “very small”And that the population should accept the vaccine when it is offered by Health.
These cases have been observed among the 18.1 million people who received this vaccine in the UK until the end of March.
Of the 30 incidents, 22 correspond to venous cerebral thrombi (CVST) and eight to other problems related to blood clotting with low platelets.
Adam Finn, member of the Joint Committee on Vaccination and Immunization (JCVI) – in charge of the country’s vaccination plan-, pointed out that the preparation is, “By far the safest option to reduce the risks of becoming seriously ill or dying from COVID-19”.
Finn, from the English University of Bristol, told the media on Friday that these cases are “very carefully researched to better understand“If there is some kind of”casual link with vaccination”.
“However, the extreme rarity of these cases in the context of many millions of doses that have been administered means that the decision about the risk or benefit that people face when they are invited to receive the COVID-19 vaccine is simple: getting the vaccine is by far the safest option”.
Regulators have pointed out that they have not received notification of clot problems in those vaccinated with the BioNTech / Pfizer preparation.
This information comes to light after Germany decided to discontinue the use of AstraZeneca for people under the age of 60 due to fears of a possible link to blood clots.
Meanwhile, the European Medicines Agency (EMA) had already indicated that “there was no evidence”To restrict the use of the AstraZeneca vaccine among the population.
In addition to this preparation, the United Kingdom is vaccinating with Pfizer’s and more than 30 million people have already received at least the first of the two doses of these vaccines.
Melissa Galbraith is the World News reporter for Globe Live Media. She covers all the major events happening around the World. From Europe to Americas, from Asia to Antarctica, Melissa covers it all. Never miss another Major World Event by bookmarking her author page right here.